3Papac RJ. Origins of cancer therapy [ J ]. Yale J Biol Med, 2001, 74(6) :391 -398.
4Schrama D, Becker JC, Reisfeld RA. Antibody targeted drugs as cancer therapeutics[J]. Nat Rev Drug Dis,2006,5:147 - 159.
5Litman GW, Rast JP, Shamblott M J, et al. Phylogenetic diversifi- cation of immunoglobulin genes and the antibody repertoire [ J]. Mol Biol Evol, 1993,10 ( 1 ) :60 - 72.
6Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the efficacy and safety of humanized anti - HER2 monoclonal antibody in women who have HER2 - overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [ J ]. J Clin Oncol, 1999,17 (9) :2639 - 2648.
7Johnson JR, Ford CH, Newman CE, et al. A vindesine - anti - CEA conjugate cytotoxic for human cancer cells in vitro[ J]. Br J Cancer, 1981,44 (3) :472 - 475.
8Garnett MC. Targeted drag conjugates: Principles and progress [ J ]. Adv Drug Deliv Rev,2001,53 (2) : 171 - 216.
